FY2025 · ended Dec 31, 2025 · Revenue $1.92B, +40.3% YoY · Filed Feb 27, 2026
Clover Health Investments, Corp. /DE (CLOV) files with the SEC under industry code 6324, Hospital & Medical Service Plans. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $1.9 billion and a net loss of $85.5 million. Free cash flow was -$69.0 million.
Revenue (TTM)
$2.48B
+54.0% vs year-ago TTM
Net income (TTM)
$-18.36M
Operating cash flow (TTM)
$77.03M
+264.8% vs year-ago TTM
Free cash flow (TTM)
$74.21M
+254.0% vs year-ago TTM
EPS (TTM)
$-0.03
Dividend per share
None
Shares outstanding
—
Net cash
$285.23M
FY 2025
Operating margin
-0.7%
FY 2026
Company profile
- Industry
- Hospital & Medical Service Plans (SIC 6324)
- Listed as
- CLOV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Jersey City, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1801170
- Former names
- Social Capital Hedosophia Holdings Corp. III (until Jan 7, 2021)
Other Hospital & Medical Service Plans companies
- Unitedhealth Group Inc UNH
- Elevance Health, Inc. ELV
- Cigna Group CI
- Humana Inc HUM
- Centene Corp CNC
- Molina Healthcare, Inc. MOH
- Oscar Health, Inc. OSCR
- Alignment Healthcare, Inc. ALHC
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $1.9B | $1.4B | $1.3B | $1.1B | $1.5B |
| Operating income | -$85.5M | -$45.7M | -$205.3M | -$286.7M | -$637.0M |
| Net income | -$85.5M | -$43.0M | -$213.4M | -$339.6M | -$587.8M |
| Diluted EPS | — | — | -$0.44 | -$0.71 | -$1.42 |
| Operating cash flow | -$66.9M | $34.8M | -$144.7M | -$203.9M | -$282.3M |
| Free cash flow | -$69.0M | $33.3M | -$145.2M | -$208.4M | -$283.0M |
| Total assets | $541.0M | $580.7M | $570.7M | $808.6M | $950.8M |
| Total liabilities | $232.3M | $239.6M | $284.3M | $451.7M | $410.8M |
| Stockholders' equity | $308.7M | $341.1M | $286.4M | $356.9M | $540.0M |
| Cash and investments | $288.5M | $423.3M | $343.8M | $430.7M | $496.7M |
| Total debt | $3.3M | $3.3M | $4.7M | $5.9M | $27.9M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 4, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 9, 2026 | Oct 8, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Sep 25, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 24, 2026 | Sep 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 20, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
All 708 Clover Health Investments, Corp. /DE SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.